CAIRO (HQ) DUBAI LONDON BOSTON
CAI –:– EET LinkedIn hello@pharmasyc.com
Legal

Privacy Policy

PharmaSync is built on confidentiality. This policy explains what limited information we hold, why we hold it, and the controls that keep your data discreet across our Cairo, Dubai, London, and Boston desks.

Effective date
June 1, 2026

This Privacy Policy describes how PharmaSync (“PharmaSync,” “we,” “us”) collects, uses, and safeguards information when you visit our website, correspond with our team, or engage us on a confidential mandate. We collect only what an advisory relationship genuinely requires, and we treat every enquiry as NDA-first by default.


Information We Collect

We collect the limited information you choose to share with us and a small set of technical signals needed to operate the site. This typically includes contact details you submit through an enquiry form (name, work email, organization, and role), the content of messages you send us, and correspondence exchanged during an engagement. When you subscribe to one of our briefings, we hold the email address you provide for that purpose only.

We do not seek sensitive personal data through this website. Confidential deal materials shared during a mandate are governed by the relevant non-disclosure agreement rather than this policy.

How We Use Information

We use the information you provide to respond to enquiries, route a request to the appropriate desk, deliver newsletters you have asked for, and conduct partner-led advisory work. We may also use aggregated, non-identifying information to understand how the site is used and to improve it. We do not use your information to make automated decisions that produce legal effects.

Cookies & Analytics

Our website uses a minimal set of cookies and similar technologies to keep the site functioning and to measure general usage. Where analytics are employed, they are configured to limit identifiability. You can adjust your browser settings to refuse or remove cookies; some convenience features may not work as intended if you do.

Sharing

We do not sell your information. We share it only where necessary: with vetted service providers who support our operations under confidentiality obligations, with parties to an engagement where you have authorized it, or where required by law or to protect our legitimate interests. Any disclosure made during a mandate is governed first by the applicable non-disclosure agreement.

Retention

We retain information only as long as needed for the purpose it was collected, to maintain an accurate record of correspondence, or to meet legal and professional obligations. When information is no longer required, we delete or anonymize it.

Your Rights

Depending on your jurisdiction, you may have the right to access, correct, delete, or restrict the processing of your personal information, to object to certain uses, or to receive a copy of the data you have provided. To exercise any of these rights, contact us using the details below and we will respond within a reasonable period.

International Transfers

PharmaSync operates as one integrated team across Cairo, Dubai, London, and Boston. As a result, information may be processed in any of these locations. Where data moves across borders, we apply appropriate safeguards consistent with the confidentiality standards that define our practice.

Security

We apply organizational and technical controls designed to protect information against unauthorized access, loss, or misuse, including access on a need-to-know basis and encryption of data in transit. No method of transmission is perfectly secure, but discretion and data protection are central to how we work.

Contact

Questions about this policy or about how we handle your information can be directed to our team. We respond to privacy enquiries within 24 hours.

Generalhello@pharmasyc.com
HeadquartersCairo, Egypt
Response timeWithin 24 hours

Template note

This Privacy Policy is provided as a placeholder for the PharmaSync rebuild and does not constitute legal advice. Final language should be reviewed by qualified counsel before publication.

Engagement

Begin a confidential conversation.

Contact us -> Response within 24 hours